KITE PHARMA INC's ticker is KITE and the CUSIP is 49803L109. A total of 227 filers reported holding KITE PHARMA INC in Q2 2017. The put-call ratio across all filers is 0.38 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2017 | $5,299,000 | +43.1% | 51,113 | +8.4% | 0.04% | +42.3% |
| Q1 2017 | $3,703,000 | +72.3% | 47,173 | -1.6% | 0.03% | +62.5% |
| Q4 2016 | $2,149,000 | -39.2% | 47,930 | -24.2% | 0.02% | -44.8% |
| Q3 2016 | $3,532,000 | +2.3% | 63,227 | -8.4% | 0.03% | -6.5% |
| Q2 2016 | $3,451,000 | +38.8% | 69,016 | +27.5% | 0.03% | +19.2% |
| Q1 2016 | $2,486,000 | -35.9% | 54,149 | -14.0% | 0.03% | -31.6% |
| Q4 2015 | $3,881,000 | – | 62,977 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|